Pharmacy World and Science

, Volume 23, Issue 5, pp 183–184 | Cite as

Identification of the pharmaceutical care issues of rheumatoid arthritis patients in secondary care

  • R. O'Hare
  • A. Muir
  • S. Chapman
  • A. Watson
  • S.A. Hudson


Objective: To explore the perceptions of multidisciplinary health care professionals (HCPs) and patients of the pharmaceutical care issues (PCIs) relating to rheumatoid arthritis (RA.).

Design: Qualitative study using semi‐structured one to one interviews and focus groups to explore patient perceptions. Interviews and focus groups were taped and transcribed verbatim, then described and coded for meaning to produce 'in‐vivo' codes, which were then grouped to form themes. Nominal group methodology was used to generate and rank a list of HCP perceptions of the key PCIs of RA patients. The PCIs were ranked according to clinical importance and order of occurrence from admission as perceived by the HCP group.

Setting: Rheumatology ward and outpatient clinic in a teaching hospital.

Main Outcome Measures: Generation and ranking of PCIs, generation of themes from patient interviews.

Results: Optimisation of pain control was identified by the nominal group as being the primary aim for patients on admission and was also the most commonly described symptom by patients. Two PCIs not predicted by the HCPs' nominal group was the frequency of infections and the associated discharge and patients described experiencing 'over‐education' by HCPs, which could lead to anxiety. Complementary medicine in conjunction with traditional therapy was raised as a significant health benefit by patients.

Conclusion: Many patients' views mirrored the PCIs identified by HCPs, but some were not anticipated; the value of patient interviews to ensure appropriate service development was demonstrated. Several PCIs emerged for future incorporation by the multi‐disciplinary team into standardised models of pharmaceutical care for use in secondary care and at the secondary/primary care interface for improvement of seamless care. There is a need to target educational interventions and to identify those who will benefit from advice on complementary medicine. Further work is required to develop a tool to identify the educational needs of RA patients and targeting of the information provided. This will help ensure the delivery of pharmaceutical care is designed to match the needs of individual patients.

Educational needs Patient needs Pharmaceutical care Rheumatoid arthritis Secondary care 


  1. 1.
    Watson MC, Dieppe PA. Issues in rheumatoid arthritis. Pharm J 1998;260:310-1Google Scholar
  2. 2.
    Akil M, Amos RS. Rheumatoid arthritis-I: Clinical features and diagnosis. BMJ 1995;310:587-90.Google Scholar
  3. 3.
    Brown WJ. Pharmacist participation on a multidisciplinary rehabilitation team. Am J Hosp Pharm 1994;51:91-2.Google Scholar
  4. 4.
    Lindroth Y, Bauman A, Barnes C et al. A controlled evaluation of arthritis education. Br J Rheumatol 1989;28:7-12.Google Scholar
  5. 5.
    Simpson D. Pharmaceutical care: the Minnesota model. Pharm J 1997;258:899-904.Google Scholar
  6. 6.
    Scottish Office Department of Health, Clinical Resource and Audit Group (CRAG). 'Clinical Pharmacy in the Hospital Pharmacy Service: A framework for practice'. HMSO, Edinburgh 1996Google Scholar
  7. 7.
    Bayraktar A, Hudson SA, Watson A, Fraser S. Pharmaceutical Care (7) Arthritis. Pharm J 2000;264:57-68.Google Scholar
  8. 8.
    Lambert BL, Butin DN, Moran D, Zhao SZ, Carr BC, Chen C, Kizis FJ. Arthritis Care: Comparison of Physicians' and Patients' Views. Semin Arthritis Rheum 2000;30:100-10.Google Scholar
  9. 9.
    Designed to Care: Renewing the NHS in Scotland. Scottish Office Department of Health. December 1997Google Scholar
  10. 10.
    Duggan C, Bates I. Development and evaluation of a survey tool to explore patients' perceptions of their prescribed drugs and their need for drug information. Int J Pharm Pract 2000;8:42-52.Google Scholar
  11. 11.
    Silvers IJ, Hovell MF, Weisman MH, Mueller MR. Assessing physician/patient perceptions in rheumatoid arthritis. Arthritis Rheum 1985;28:300-7Google Scholar
  12. 12.
    Himmel W, Tabache M, Kochen MM What happens to long-term medication when general practice patients are referred to hospital? Eur J Clin Pharmacology 1996;50: 253-7Google Scholar
  13. 13.
    Cochrane RA, Mandal AR, Ledger-Scott M, Walker R. Changes in drug treatment after discharge from hospital in geriatric patients. BMJ 1992;305: 694-6Google Scholar
  14. 14.
    Rahimtoola H, Timmers A, Dessing R, Hudson S. Community pharmacy records in the development of pharmaceutical care in the Netherlands. Pharm World Sci 1997;19: 105-13Google Scholar

Copyright information

© Kluwer Academic Publishers 2001

Authors and Affiliations

  • R. O'Hare
    • 1
  • A. Muir
    • 1
  • S. Chapman
    • 1
  • A. Watson
    • 1
  • S.A. Hudson
    • 1
  1. 1.South Glasgow University Hospitals NHS Trust, Greater Glasgow Pharmacy Practice Unit, Department of Pharmaceutical SciencesUniversity of StrathclydeGlasgowScotland, UK

Personalised recommendations